Lacosamide Market
Lacosamide Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Lacosamide Market Size and Growth
Lacosamide market research reports indicate a growing demand, driven by increasing prevalence of epilepsy and neuropathic pain. The global market size was valued at approximately USD 1.2 billion in 2022, with expectations for significant growth due to advancements in pharmaceutical formulations and an expanding patient population seeking effective treatment options. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ UCB
◍ Teva
◍ Amneal Pharmaceuticals
◍ MSN Laboratories
◍ Alembic Pharma
◍ Glenmark
◍ Aurobindo Pharma
◍ Accord Healthcare
◍ Mylan
◍ Sun Pharma
◍ Apotex
The Lacosamide market features key players like UCB, Teva, Amneal, and others, focusing on generics and branded formulations. These companies drive market growth through strategic partnerships, innovation, and expanding access. Revenue highlights include UCB’s peak sales over $700 million and Teva's significant generic contributions, enhancing market presence and accessibility.
Request Sample Report
Market Segmentation
By Application
Adults
Pediatric patients
Request Sample Report
By Product
Oral tablets
Oral solution
Intravenous
Market Growth
Request Sample Report
$ 5.03 Billion
